Bioequivalence Study Comparing Two Pomalidomide 4 mg Capsule Formulations in Healthy Male Subjects

NCT07694011 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Pomalidomide Bioequivalence Study in Healthy Volunteers

Interventions

DRUG: Xetrane® (Pomalidomide) 4 mg Hard Capsule
DRUG: Imnovid® (Pomalidomide) 4 mg Hard Capsule

Sponsor

Knight Therapeutics (USA) Inc

Collaborators

[object Object]